NR4A1 and neoplasm: Gene expression cDNA microarray studies indicated that within the hormone-receptor positive (luminal) tumours there are at least 2 subtypes, Luminal A and B. Each subtype is characterized with a distinct gene expression and prognosis, Luminal B giving poorer outcomes [6, 7].